Annual Cash & Cash Equivalents
$77.42 M
-$205.27 M-72.61%
December 31, 2021
Summary
- As of February 10, 2025, FMTX annual cash & cash equivalents is $77.42 million, with the most recent change of -$205.27 million (-72.61%) on December 31, 2021.
- During the last 3 years, FMTX annual cash & cash equivalents has fallen by -$6.03 million (-7.22%).
Performance
FMTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$75.14 M
+$721.00 K+0.97%
June 30, 2022
Summary
- As of February 10, 2025, FMTX quarterly cash and cash equivalents is $75.14 million, with the most recent change of +$721.00 thousand (+0.97%) on June 30, 2022.
- Over the past year, FMTX quarterly cash and cash equivalents has increased by +$24.26 million (+47.69%).
Performance
FMTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
FMTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.6% | +47.7% |
| 3 y3 years | -7.2% | - |
| 5 y5 years | -7.2% | - |
FMTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -3.0% | -1.0% |
| 5 y | 5-year | -72.6% | at low | -80.0% | -32.3% |
| alltime | all time | -72.6% | at low | -80.0% | -32.3% |
Forma Therapeutics Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $75.14 M(+1.0%) |
| Mar 2022 | - | $74.42 M(-3.9%) |
| Dec 2021 | $77.42 M(-72.6%) | $77.42 M(-11.3%) |
| Sep 2021 | - | $87.25 M(+71.5%) |
| Jun 2021 | - | $50.87 M(-48.0%) |
| Mar 2021 | - | $97.83 M(-65.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $282.69 M(+63.2%) | $282.69 M(+254.0%) |
| Sep 2020 | - | $79.86 M(-78.7%) |
| Jun 2020 | - | $374.95 M(+239.8%) |
| Mar 2020 | - | $110.33 M(-36.3%) |
| Dec 2019 | $173.18 M(+107.5%) | $173.18 M |
| Dec 2018 | $83.45 M | - |
FAQ
- What is Forma Therapeutics Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Forma Therapeutics Holdings?
- What is Forma Therapeutics Holdings annual cash & cash equivalents year-on-year change?
- What is Forma Therapeutics Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Forma Therapeutics Holdings?
- What is Forma Therapeutics Holdings quarterly cash and cash equivalents year-on-year change?
What is Forma Therapeutics Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of FMTX is $77.42 M
What is the all time high annual cash & cash equivalents for Forma Therapeutics Holdings?
Forma Therapeutics Holdings all-time high annual cash & cash equivalents is $282.69 M
What is Forma Therapeutics Holdings annual cash & cash equivalents year-on-year change?
Over the past year, FMTX annual cash & cash equivalents has changed by -$205.27 M (-72.61%)
What is Forma Therapeutics Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FMTX is $75.14 M
What is the all time high quarterly cash and cash equivalents for Forma Therapeutics Holdings?
Forma Therapeutics Holdings all-time high quarterly cash and cash equivalents is $374.95 M
What is Forma Therapeutics Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, FMTX quarterly cash and cash equivalents has changed by +$24.26 M (+47.69%)